A conversation with Dirk Rodgers: Approaching DSCSA 2023
Original air date: February 15, 2019
ABOUT THE SHOW:
In the writing of the Drug Supply Chain Security Act (DSCSA) law, it was understood that between the law's enactment (in 2013) and this later stage (2023), there may be changes to the issues in the supply chain, the business and certainly to technology. We talked to Dirk about the reconsideration of all these aspects in light of the 2023 requirements, as well as what's happening in the industry to prepare for 2023, now that the serialization date has passed.
ABOUT OUR GUEST:
Dirk Rodgers, is a Global Regulatory Strategist with expertise in pharma and medical device supply chain collaboration technologies including serialization, track & trace data exchange and management using GS1 and HIBCC standards as applied to complying with national regulatory requirements. He is well-known for his unparalleled understanding of the new Drug Supply Chain Security Act (DSCSA) and the Unique Device Identification (UDI) regulation and how to meet them using technology. He founded RxTrace in 2009 as an educational tool and source of healthy industry debate.
Dirk can be reached at: email@example.com